![](/img/cover-not-exists.png)
EMPAGLIFLOZIN ADMINISTRATION PREVENTS THE DEVELOPMENT OF MYOCARDIAL FIBROSIS IN ANGIOTENSIN II-DEPENDENT HYPERTENSION
Colzani, M., Di Gioia, C., Carletti, R., Ippolito, S., Barzaghi, F., Stella, A., Zerbini, G., Perseghin, G., Castoldi, G.Volume:
37
Journal:
Journal of Hypertension
DOI:
10.1097/01.hjh.0000571840.82099.56
Date:
July, 2019
File:
PDF, 203 KB
2019